Total amount raised
$173.2 Millions
Latest funding date
6/1/2024
Location
Eko Health has successfully raised over $125 million across multiple funding rounds, with the latest being a Series D. The company specializes in digital stethoscopes and AI-powered disease detection, offering innovative solutions for healthcare professionals.
Keep reading to explore the intricacies of Eko Health's fundraising journey and the diverse group of investors backing this cutting-edge platform.
What Is Eko Health?
Founded in 2013, Eko Health is based in Emeryville, California. The company was established by Connor Landgraf, Jason Bellet, and Tyler Crouch. Eko Health specializes in digital stethoscopes and AI-powered disease detection, aiming to revolutionize how healthcare professionals diagnose and monitor heart and lung conditions.
With a team of 101-250 employees, Eko Health offers a range of products including the CORE 500™ Digital Stethoscope and the 3M™ Littmann® CORE Digital Stethoscope. Their technology integrates advanced audio, waveforms, and AI analysis to enhance clinical expertise.
By leveraging AI and telehealth solutions, Eko Health strives to improve patient care and clinical outcomes. Their innovative approach has garnered trust from half a million clinicians and numerous FDA clearances.
How Much Funding Has Eko Health Raised?
- Series D
- Amount Raised: $41M
- Date: June 2024
- Lead Investors: ARTIS Ventures, Highland Capital Partners, NTTVC, Questa Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand U.S. and global access to Eko's early disease detection platform.
- Grant
- Amount Raised: $2.7M
- Date: September 2022
- Lead Investors: National Institutes of Health
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support research and development in AI-driven disease detection.
- Series C
- Amount Raised: $30M
- Date: March 2022
- Lead Investors: Morningside, PROOF
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale operations and enhance AI capabilities.
- Series C
- Amount Raised: $65M
- Date: November 2020
- Lead Investors: Highland Capital Partners, Questa Capital Management
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand market reach and accelerate product development.
- Grant
- Amount Raised: $2.7M
- Date: July 2020
- Lead Investors: National Institutes of Health
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To fund AI research for disease detection.
- Venture Round
- Amount Raised: $4M
- Date: January 2020
- Lead Investors: EDBI, Peak XV Partners
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To support early-stage growth and product development.
- Series B
- Amount Raised: $20M
- Date: September 2019
- Lead Investors: Artis Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand market presence and enhance product offerings.
- Series A
- Amount Raised: $5M
- Date: March 2018
- Lead Investors: Artis Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To develop and launch initial products.
- Non-Equity Assistance
- Amount Raised: Not publicly disclosed
- Date: September 2016
- Lead Investors: Dreamit Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To receive mentorship and resources for early-stage growth.
- Seed Round
- Amount Raised: Not publicly disclosed
- Date: March 2016
- Lead Investors: Not publicly disclosed
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To kickstart the company and develop initial technology.
Eko Health has raised a total of $170.4M. The current valuation is not publicly disclosed.
Key Investors
- Highland Capital Partners
- Details: Highland Capital Partners is a global venture capital firm that focuses on early and growth-stage investments. They have a strong track record in supporting innovative companies across various sectors.
- Investment Focus Areas: Technology, healthcare, consumer, enterprise software
- Notable Investments: 2U, Rent the Runway, Scopely
- Questa Capital
- Details: Questa Capital is a venture growth equity firm that specializes in healthcare investments. They aim to support companies that are transforming the healthcare landscape.
- Investment Focus Areas: Healthcare services, healthcare IT, medical devices
- Notable Investments: Medrio, DispatchHealth, Thirty Madison
- Artis Ventures
- Details: Artis Ventures invests in early-stage and growth-stage companies in the technology and life sciences sectors. They focus on companies that leverage AI and other advanced technologies.
- Investment Focus Areas: Technology, life sciences
- Notable Investments: Stemcentrx, Palantir Technologies, YouTube
- NTTVC
- Details: NTTVC is a venture capital firm backed by NTT Group, focusing on technology-driven companies. They aim to support innovative solutions that can scale globally.
- Investment Focus Areas: Technology, healthcare, enterprise solutions
- Notable Investments: Celona, Eko Health
- Morningside Technology Ventures Limited
- Details: Morningside Technology Ventures Limited is a private investment group that invests in early-stage life sciences and technology companies. They have a global investment approach.
- Investment Focus Areas: Life sciences, technology
- Notable Investments: Moderna, Apellis Pharmaceuticals
What's Next for Eko Health?
With the recent $41 million Series D funding, Eko Health is poised to expand its AI-driven heart and lung disease detection platform both in the U.S. and globally. The opportunity to introduce sophisticated detection capabilities into various physical exams, including primary care and maternal-fetal health exams, is vast. Leveraging their extensive dataset of digital heart and lung sounds, Eko Health aims to develop clinical AI for broader applications, potentially reaching millions of patients worldwide.
Future fundraising opportunities appear promising, with strategic investments from global investors like Double Point Ventures, EDBI, and LG Technology Ventures. These partnerships suggest ongoing interest and potential for additional funding rounds to further scale their technology and market reach. However, Eko Health may face challenges such as navigating regulatory approvals in different countries, competition from other AI-driven medical technology companies, and ensuring the scalability and reliability of their platform in diverse healthcare settings.
Use Clay to Get Funding Data
Sales professionals, take advantage of Clay's platform to access comprehensive fundraising data on companies like Eko Health and gather other critical business insights. Sign up for free today and elevate your sales strategy with the most up-to-date information at your fingertips.
